Worldwide, cervical cancer was the fourth most common cancer among females in 2012, accounting for 7.5% of all female cancer deaths. About 87% of cervical cancer deaths occurred in the less developed regions [1]. In Egypt, according to the World Health Organization (WHO) most recent estimates, every year 866 women are diagnosed with cervical cancer and 373 die from the disease. Cervical cancer ranks as the 13th most frequent cancer among women in Egypt and the 10th most frequent cancer among women between 15 and 44 years of age in 2012 [2]. CIN is a spectrum of intra-epithelial cellular abnormality suggestive of neoplasia. The process of dysplasia of cervical cells means abnormal maturation. [3] According to Bethesda system 2014, CIN is classified into three grades which include mild, moderate and severe degrees (CIN 1, 2 and 3 respectively). The main risk factors for cervical dysplasia include HPV infection with serotypes 16, 18, 31, 33, 35 [4]. Other risk factors include early sexual activity, smoking, high parity and immunosuppression. Screening of pre-invasive disease of the Cervix aims to prevent morbidity and mortality from cervical cancer. Screening starts at the age of 21and continues till the age of 65years. Methods for cervical screening: The main screening methods of cervical cancer are: 1) Cervical cytological screening (Pap smear); 2) Visual inspection with acetic acid (VIA); 3) Visual inspection with Lugol’s iodine (VILI); 4) Colposcopy; and 5) Cervical biopsies. The conventional method (Pap smear): The Pap test was developed by Dr. George Papanicolaou in 1941. Cervical screening always requires an endocervical and an ectocervical sample, using wooden or plastic spatulas: Ayre and extended tip or Aylesbury [5]. Exfoliated cells are collected from the transformation zone of the cervix and transferred directly to the slide and fixed using the conventional technique. In practice, there are several problems with the Pap test. They include the adequacy of the samples, the difficulty of microscopic screening, based on recognizing few abnormal cells among many thousands of cells in each sample as well as high rate of false negative results. Liquid-based technology (LBC) is a newer technique that employs liquid-based cytology (e.g. Thin Prep) have been developed to improve the sensitivity of screening. LBC involves placing the cervical sample directly into a liquid fixative; slide preparation occurs in the laboratory. Improved slide preparation can allow for a more even distribution of cells and decreased background artifact and overlapping of cells. Disadvantages of LBC approach are lack of availability and being more expensive than conventional Pap testing. The Bethesda System the standard universal system used for interpretation of Pap smear results [6]. Types of results using Betheseda system include: Negative for intraepithelial lesion or malignant atypical squamous cells. 1) Atypical squamous cells of undetermined significance (ASC-US); 2) Atypical squamous cells-cannot exclude HSIL (ASC-H); 3) Low grade squamous intraepithelial lesion (LGSIL or LSIL); 4) High grade squamous intraepithelial lesion (HGSIL or HSIL); 5) Squamous cell carcinoma; 6) Atypical Glandular Cells not otherwise specified (AGC-NOS); 7) Atypical Glandular Cells, suspicious for AIS or cancer (AGC-neoplastic); 8) Adenocarcinoma in situ (AIS); 9) Adenocarcinoma. Low grade lesions correspond to CIN1 and high grade lesions correspond to CIN 2 and 3.

The aim of work is to assess the prevalence of abnormal cervical cytology in Al Shatby Maternity University Hospital of Alexandria, Egypt, patients using Pap smear.

1000 women, median age 43 years (range 21 - 65), attending the Gynecology Clinic at El-Shatby Maternity Hospital, Alexandria University Hospital over a 12-month period, starting from February 2019 to January 2020 were enrolled in the study after taking a written consent and approval of ethics committee.

The sample size was determined by the medical research institute, department of statistics to evaluate the accuracy of this statistical work.

Statistical analysis of the data [7]:

Data were fed to the computer and analyzed using IBM SPSS software package version 20.0. (Armonk, NY: IBM Corp) [8] Qualitative data were described using number and percent. The Kolmogorov-Smirnov test was used to verify the normality of distribution Quantitative data were described using range (minimum and maximum), mean, standard deviation and median. Significance of the obtained results was judged at the 5% level

Cervical cancer (CC) is a preventable neoplasm with known etiology and precursor lesions of slow evolution, could to be screened. Cervical cancer remains a huge burden in developing countries where cervical cancer screening rates are currently low, ranging between 6% - 8% [9].

A systematic analysis of cervical cancer in 187 countries between 1980 and 2010 found that developed countries with comprehensive cancer screening programs have recorded sustained declines in cervical cancer incidence and mortality while many developing countries in sub-Saharan Africa have experienced upsurges in new cases [10].

In Egypt early detection of precancerous cervical lesions through screening remains a critical health care service intervention for reducing cervical cancer incidence and mortality particularly in low-resource settings where HPV vaccination coverage is poor [11].

Cytology-based screening is a highly effective method of secondary prevention and control of cervical cancer in developed countries. (82, 83) Nearly all cervical cancer cases arise from CIN lesions, but not all CIN lesions progress to cancer. Actually, many persist without change or even regress. (84) It is believed that CIN I and II are more likely to regress than to progress; only 10.0%-15.0% of CIN I lesions are progress to CIN II and III/CIS, and 50.0% of CIN II and 30.0% of CIN III regress spontaneously [12] [13] [14] [15].

Our current study was conducted on 1000 patients from Al-Shatby Maternity University Hospital outpatient clinic. Smear results were categorized into 3 main groups; normal, inflammatory and abnormal (+ve intraepithelial neoplasia). 37.7% of patients were normal, 45.3% of them showed an inflammatory smear (the majority of cases) and 17% of them showed abnormal cytology results. Cases with abnormal cervical cytology (ACC) were due to ASCUS in 11.1%, LSIL in 2.9%, HSIL in 1.3%, ASC-H in 1.1%, AGS-NO in 0.3% and AGS-favour neoplasia in 0.3% of cases. This means that the majority of cellular abnormality we found was ASCUS which represent almost one tenth of cases of cases of abnormal cytology. This was agreement with Mosuro et al. (2015) and Richter et al. (2013) who reported that 59.3% of smears were inflammatory and 16.4% were abnormal cervical cytology [16] [17].

The prevalence of abnormal cytology in the age group from 30 to 40 years in our study was much more predominant than any other age category. This finding was in accordance with Sanad et al. (2014) who found that prevalence of ACC in age group <30 was significantly lower than in middle age group [18].

High parity was always been a risk factor for ACC. The American Cancer Society [19] and Mahalli et al. [20] reported that women with high parity (≥3) have increased risk of ACC and CC. We reported the same finding in our study where 69% of abnormal cytology was reported in females having high parity ≥ 3. This finding may be attributed to HPV exposure with unprotected intercourse and immunosuppression that occurs during pregnancy which may contribute to oncogenesis.

In our study we found a significant association between young age of first intercourse and abnormal cervical cytology, as 60.2% of ACC was found in patients who were sexually active before age of 20, so there was agreement with El-Moselhy et al. (2015) [21] who reported the same significant association between early age of marriage (<20) and cytological abnormality.

In our study there was 53% of cervical cytological abnormality in patients who had normal vaginal delivery which was more than other patients group (nullipara, had CS delivery), as these women were exposed to more cervical trauma during vaginal delivery especially multipara women, this with agreement with Skegg et al. (2013) [22] who found that women who had vaginal delivery were at higher risk of cervical cancer than who deliver by CS especially multiparous women with low social class.

Cigarette smoking is established as a cofactor of HPV for cervical cancer. The prevalence of HPV is increased in associated with active smoking it seems that the risk is dose-dependent and disappears after smoking cessation [23]. In our study 60.9% of ACC was among smoker patients (active and passive), 42.7% of abnormal cervical cytology found among passive smoker patients, this was agreement with Min, Kyung-Jin et al. (2017) [24] who reported that passive smoking among non-smokers is associated with the risk of CIN, especially non-smoking women who exposed to passive smoking for 2 or more hours per day.

Lower social class women are more likely to develop cervical cancer than those with higher social class. In Egypt, most patients with low social classes reside in rural areas. We found in our study that women from rural areas have higher incidence of ACC than those who reside in urban ones. We found that 78.9% of those patients come from rural areas with low social status. These findings were also in accordance with those found by El-Moselhyet al. (2017) who reported that there is a strong correlation between socioeconomic class and abnormal cytology results [25].

In our study there was a significant difference regarding number of previous marriages and development of cervical cell abnormalities. The incidence of ACC in patients who married only once was 13.3%, and it was 56.5% in women who had twice or more previous marriages. This was in agreement with Mosuroet al. (2015) [16] who reported higher cervical cytological abnormality between patients with multiple life time partners.

In our study we found that there was decrease incidence of ACC between IUD users was lower than non IUD users. Castellsague et al. (2011) [26] also found that the use of IUD use is a protective factor against ACC. This was explained by the cellular immunity triggered by the IUD. Researchers have theories that could explain how the IUD protects from developing CC. One theory states that the procedure of inserting the IUD may destroy HPV lesions before they become cancerous [27].

We found some decrease of abnormal cytology between condom to male this with agreement with El. Mahalli et al. (2015) [20] as it reported that usage of condom to male will lower the risk of STD infection and also abnormal cytology So, the condom was reported a statistically significant protective factor.

Our study reported that the use of oral contraceptive pills (OCs) was associated with increase of ACC. We reported that 42.9% of patients with ACC were pill users. El-Moselhy et al. (2016) [25] and other studies also reported that OCs usage for long duration was a significant risk factors for development of ACC. This effect may be due to increasing the susceptibility of cervical cells to persistent infection with high-risk HPV types.

Cervical cytology remains the gold standard for cervical cancer screening and the use of the Bethesda system is a simple and accurate method for diagnosis and management of cases with abnormal cervical cytology.

· Cervical cancer screening programs need to be applied to women in our country to decrease the burden of CIN and cancer cervix.

· We need to teach all females in our country about importance of cervical screening.

The authors declare no conflicts of interest regarding the publication of this paper.

Essmat, A., Meleis, M., Elsokkary, H., Ahmed, S.S. and El-Soody, E. (2021) Study of Prevalence of Abnormal Cervical Cytology in Al-Shatby Maternity University Hospital. Open Journal of Obstetrics and Gynecology, 11, 434-449. https://doi.org/10.4236/ojog.2021.114042